A detailed history of New York State Common Retirement Fund transactions in Morphic Holding, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 16,419 shares of MORF stock, worth $559,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,419
Previous 16,358 0.37%
Holding current value
$559,395
Previous $472,000 22.46%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$26.64 - $40.31 $1,625 - $2,458
61 Added 0.37%
16,419 $578,000
Q4 2023

Feb 01, 2024

BUY
$19.95 - $31.0 $65,376 - $101,587
3,277 Added 25.05%
16,358 $472,000
Q3 2023

Nov 07, 2023

BUY
$21.33 - $59.42 $1,279 - $3,565
60 Added 0.46%
13,081 $300,000
Q2 2023

Aug 07, 2023

SELL
$34.33 - $62.11 $40,578 - $73,414
-1,182 Reduced 8.32%
13,021 $746,000
Q1 2023

May 02, 2023

SELL
$26.01 - $48.69 $133,093 - $249,146
-5,117 Reduced 26.49%
14,203 $535,000
Q4 2022

Jan 30, 2023

SELL
$24.14 - $30.37 $603 - $759
-25 Reduced 0.13%
19,320 $517,000
Q3 2022

Nov 08, 2022

BUY
$22.23 - $33.37 $2,178 - $3,270
98 Added 0.51%
19,345 $547,000
Q2 2022

Aug 04, 2022

BUY
$19.74 - $43.01 $84,092 - $183,222
4,260 Added 28.42%
19,247 $418,000
Q1 2022

May 05, 2022

BUY
$36.25 - $52.02 $181 - $260
5 Added 0.03%
14,987 $602,000
Q4 2021

Feb 02, 2022

SELL
$43.27 - $65.72 $1,730 - $2,628
-40 Reduced 0.27%
14,982 $710,000
Q3 2021

Nov 02, 2021

SELL
$53.61 - $67.5 $155,200 - $195,412
-2,895 Reduced 16.16%
15,022 $851,000
Q2 2021

Aug 02, 2021

BUY
$45.13 - $64.99 $226,326 - $325,924
5,015 Added 38.87%
17,917 $1.03 Million
Q1 2021

May 11, 2021

BUY
$29.77 - $84.85 $23,816 - $67,880
800 Added 6.61%
12,902 $816,000
Q2 2020

Aug 07, 2020

BUY
$12.65 - $29.57 $80,985 - $189,307
6,402 Added 112.32%
12,102 $327,000
Q3 2019

Nov 07, 2019

BUY
$17.46 - $29.05 $99,522 - $165,585
5,700 New
5,700 $103,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.